ABCG22 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to ABCG2 Antibody

The ABCG2 antibody targets the ATP-binding cassette subfamily G member 2 (ABCG2), a half-transporter protein critical for effluxing chemotherapeutic agents, uric acid, and porphyrins. It is implicated in multidrug resistance (MDR), stem cell regulation, and inflammatory diseases. While the query refers to "ABCG22 Antibody," this term does not appear in scientific literature; it is likely a typographical error for ABCG2 Antibody, which is extensively studied. This article focuses on ABCG2 antibodies, their molecular structure, clinical relevance, and research applications.

Molecular Structure and Function of ABCG2

ABCG2 is a homodimeric protein with two nucleotide-binding domains (NBDs) and transmembrane domains (TMDs) arranged in an inverted topology compared to other ABC transporters . Key functional regions include:

  • Drug-binding pockets: Located in TMDs, these interact with substrates like daunorubicin and mitoxantrone .

  • Q141K and R482 variants: Polymorphisms (e.g., Q141K) reduce functional expression, increasing drug accumulation and urate secretion .

  • Hinge region: Critical for conformational changes during substrate transport .

ABCG2’s role in stem cell protection, cancer resistance, and uric acid excretion is well-documented .

Types of ABCG2 Antibodies and Their Applications

ABCG2 antibodies are classified by their epitopes and applications (Table 1).

Antibody CloneEpitopeApplicationsSourceReferences
5D3Extracellular loopFlow cytometry, immunohistochemistryR&D Systems
BXP-21C-terminal domainWestern blot, confocal microscopyAbcam
D5V2KFull-length proteinWestern blot, immunoprecipitationCell Signaling
Picoband® A00457N-terminal domainELISA, flow cytometry, IHCBoster Bio

Key features:

  • 5D3: Binds live cells for flow cytometry, enabling analysis of ABCG2 expression in hematopoietic stem cells .

  • BXP-21: Detects ABCG2 in transfected HEK293 cells and polarized MDCKII cells, aiding in localization studies .

  • D5V2K: Validated for immunoprecipitation, ideal for studying protein interactions .

Clinical and Research Significance

ABCG2 antibodies are pivotal in studying its role in disease and drug resistance:

Cancer Drug Resistance

ABCG2 overexpression in acute myeloid leukemia (AML) correlates with poor prognosis due to efflux of anthracyclines and mitoxantrone . Studies using 5D3 and BXP-21 antibodies have shown:

  • Q141K variant: Reduced surface expression and substrate transport efficiency .

  • R482G mutation: Altered substrate specificity and cholesterol regulation .

Stem Cell Markers

ABCG2 is a marker for limbal epithelial stem cells, identified via 5D3 staining in flow cytometry and immunohistochemistry . ABCG2-positive cells exhibit higher colony-forming efficiency (CFE) compared to negative populations .

Inflammatory Diseases

In psoriasis, ABCG2 polymorphisms like Q141K are associated with reduced disease risk and elevated serum urate levels . Antibodies like Picoband® A00457 are used to correlate ABCG2 expression with immune cell migration and cytokine secretion .

Challenges and Emerging Research Directions

  • Standardization: Variability in ABCG2 detection methods (e.g., flow cytometry vs. Western blot) complicates cross-study comparisons .

  • Inhibitor Development: While ribociclib and talazoparib show promise as ABCG2 inhibitors, no clinical trials are active .

  • Structural Models: Homology models based on ABCG5-ABCG8 provide insights into substrate binding and mutation effects but require validation .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
ABCG22; WBC23; At5g06530; F15M7.6; ABC transporter G family member 22; ABC transporter ABCG.22; AtABCG22; White-brown complex homolog protein 23; AtWBC23
Target Names
ABCG22
Uniprot No.

Target Background

Gene References Into Functions
PMID: 21575091, https://www.ncbi.nlm.nih.gov/pubmed/21575091, AtABCG22 is essential for stomatal regulation in Arabidopsis. The *atabcg22* mutant exhibited lower leaf temperatures and increased water loss, suggesting enhanced transpiration due to altered stomatal control., .
Database Links

KEGG: ath:AT5G06530

STRING: 3702.AT5G06530.1

UniGene: At.20832

Protein Families
ABC transporter superfamily, ABCG family, Eye pigment precursor importer (TC 3.A.1.204) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is ABCG22 and what cellular functions does it perform?

ABCG22 (also known as AtABCG22 in Arabidopsis thaliana) belongs to the ATP-binding cassette (ABC) transporter superfamily, specifically the G subfamily. Studies of atabcg22 mutant plants have demonstrated lower leaf temperatures and increased water loss, indicating elevated transpiration through altered stomatal regulation . This suggests ABCG22 plays a critical role in plant water homeostasis by regulating transpiration.

As an ABC transporter, ABCG22 functions as a membrane-bound protein that uses ATP to transport specific substrates across biological membranes. While the exact substrates remain under investigation, current evidence suggests it may transport molecules involved in stomatal regulation pathways, potentially contributing to drought resistance mechanisms in plants.

How are antibodies against ABC transporters typically generated?

Generation of antibodies against ABC transporters like ABCG22 typically involves the following methodology:

  • Epitope selection: Identifying unique peptide sequences from the target transporter with minimal homology to other proteins, particularly other ABC family members

  • Immunogen preparation: Conjugating the selected peptide to carrier proteins like KLH (Keyhole Limpet Hemocyanin) to enhance immunogenicity

  • Host immunization: Typically using rabbits for polyclonal antibodies or mice for monoclonal antibody development

  • Antibody purification: Collecting and purifying antibodies from serum using affinity chromatography

  • Validation: Rigorous testing against positive and negative controls

For example, the anti-PDR8 antibody (against a related ABC transporter) was generated using "KLH-conjugated synthetic peptide derived from Arabidopsis thaliana PDR8" and produced in rabbits as a polyclonal antibody . The choice of immunogen is particularly critical for ABC transporters due to their high sequence similarity within subfamilies.

What are the key considerations when selecting an anti-ABCG22 antibody for research?

When selecting an anti-ABCG22 antibody for research, consider these critical parameters:

Selection CriteriaImportant ConsiderationsExamples from Literature
SpecificityCross-reactivity with related ABC transportersAntibodies should be tested against wild-type and knockout samples
Application compatibilityValidated for specific techniquesAnti-PDR8 antibody validated specifically for Western blot at 1:10,000 dilution
Species reactivityRecognition of target across speciesAnti-PDR8 confirmed in A. thaliana, predicted for C. sativa and E. salsugineum
Epitope locationAccessibility in different applicationsConsider topology of ABCG22 in membrane for immunolocalization studies
Format and storagePreparation, reconstitution, stabilityExample: lyophilized antibodies requiring reconstitution in 50 μl sterile water
Molecular weight detectionConfirmation of target sizeExpected MW for related transporter PDR8/ABCG36: 165 kDa

Most critically, validation data should demonstrate the antibody detects proteins of the expected molecular weight and shows reduced or absent signal in genetic knockout or knockdown systems.

What is the difference between polyclonal and monoclonal antibodies in ABC transporter research?

For ABC transporter research, the choice between polyclonal and monoclonal antibodies significantly impacts experimental outcomes:

Polyclonal Antibodies in ABC Transporter Research:

  • Recognize multiple epitopes on the transporter protein

  • Provide stronger signals useful for detecting low-abundance membrane transporters

  • More tolerant of minor protein denaturation, beneficial for different experimental conditions

  • Example: The anti-PDR8 antibody used in plant research is polyclonal, generated in rabbits

  • Particularly useful for initial detection and localization studies

Monoclonal Antibodies in ABC Transporter Research:

  • Recognize a single epitope with high specificity

  • Essential for distinguishing between closely related ABC transporters

  • Provide consistent results between experiments and antibody batches

  • Valuable for quantitative analyses requiring precise reproducibility

  • Can be more affected if post-translational modifications alter the target epitope

The appropriate choice depends on the research question, with polyclonals offering higher sensitivity for detection and monoclonals providing greater specificity for distinguishing between related transporters in the ABC family.

How should I optimize western blot protocols for detecting ABCG22 with antibodies?

Optimizing western blot protocols for ABCG22 requires specific considerations due to its nature as a high-molecular-weight membrane transporter:

Sample Preparation:

  • Microsomal fraction preparation improves detection compared to total protein extracts for membrane proteins

  • Example methodology: Compare total protein (T) with microsomal protein fraction (M/P100) as demonstrated for related transporters

  • Use mild detergents for solubilization (e.g., 1% Triton X-100 or 0.5% DDM)

  • Denature at lower temperatures (65°C for 5 minutes rather than boiling)

Gel Electrophoresis and Transfer:

  • Use lower percentage gels (8% SDS-PAGE) to better resolve high molecular weight ABC transporters

  • Load sufficient protein (30-40 μg; 37 μg used in published protocols)

  • For large proteins, employ tank transfer systems (50V for 70 minutes) rather than semi-dry methods

  • Use 0.45 μm pore size membranes rather than 0.2 μm for larger proteins

Antibody Incubation and Detection:

  • Block with PBS+0.1% Tween 20 (PBS-T)+5% milk at room temperature

  • Optimal primary antibody dilution may need titration (e.g., 1:10,000 for related transporters)

  • Incubate primary antibody overnight at 4°C for improved sensitivity

  • Include positive controls (wild-type samples) and negative controls (knockout/knockdown samples)

These optimizations address the particular challenges of ABC transporters, including their hydrophobic nature, high molecular weight, and often low native expression levels.

What are the recommended methods for validating ABCG22 antibody specificity?

Validating antibody specificity is particularly important for ABC transporters due to sequence homology within families. A comprehensive validation approach includes:

  • Genetic validation:

    • Compare wild-type samples with knockout/knockdown mutants

    • Example: Studies comparing Col-0 (wild-type) with pen3-1 (knockdown) for the related PDR8/ABCG36 transporter

    • Absence or reduction of signal in mutant samples confirms specificity

  • Overexpression systems:

    • Compare endogenous expression with samples overexpressing tagged versions

    • Example: Comparison with PEN3-GFP/pen3-1, where the fusion protein appears at higher molecular weight (192 kDa vs. 165 kDa)

    • Signal at the appropriate molecular weight confirms specificity

  • Peptide competition assay:

    • Pre-incubate antibody with the immunogenic peptide

    • Signal reduction/elimination confirms epitope-specific binding

  • Cross-species validation:

    • Test antibody on samples from different species with known sequence homology

    • Example: Documenting reactivity across species (confirmed in A. thaliana, predicted in C. sativa)

  • Immunoprecipitation and mass spectrometry:

    • Confirm antibody pulls down the correct protein using peptide sequencing

    • Particularly valuable for novel antibodies

How can I quantify ABCG22 expression levels in different tissue samples?

Several methodologies can be employed for quantitative analysis of ABCG22 protein expression:

  • Quantitative Western Blotting:

    • Include recombinant ABCG22 standard curve

    • Use digital imaging systems with dynamic range verification

    • Normalize to appropriate membrane protein loading controls

    • Calculate relative expression compared to controls

  • Flow Cytometry (for single-cell preparations):

    • Adapt methods developed for other ABC transporters that enable quantitation "from only a drop of blood"

    • Particularly useful for plant protoplasts expressing ABCG22

    • Requires fluorescently labeled antibodies and permeabilization protocols

  • ELISA-based Quantification:

    • Develop sandwich ELISA using anti-ABCG22 capture and detection antibodies

    • Generate standard curves with recombinant protein fragments

    • Useful for processing multiple samples simultaneously

  • Mass Spectrometry-based Approaches:

    • Use stable isotope-labeled peptides as internal standards

    • Target peptides unique to ABCG22 for specific quantification

    • Particularly valuable for distinguishing between closely related transporters

  • Correlation with Genetic Analysis:

    • Link protein expression measurements to genetic analysis

    • Identify mutations affecting expression as demonstrated for related transporters

    • Create expression profiles across tissues and conditions

The optimal method depends on available equipment, sample types, and research questions. For membrane proteins like ABCG22, extraction protocols must effectively solubilize the protein without damaging antibody epitopes.

What approaches are most effective for immunolocalization of ABCG22 in plant tissues?

Immunolocalization of membrane transporters like ABCG22 requires specialized approaches:

Sample Preparation:

  • Use fixatives that preserve membrane structure while allowing antibody access

  • For plant tissues, 4% paraformaldehyde with controlled permeabilization

  • Consider cryosectioning to maintain antigen accessibility

  • Sample thickness affects antibody penetration (30-50 μm optimal for many applications)

Epitope Accessibility Considerations:

  • Analyze ABCG22 topology to determine if epitopes are extracellular, intracellular, or transmembrane

  • For intracellular domains, controlled membrane permeabilization is necessary

  • Extracellular epitopes may be accessible without permeabilization

Controls and Validation:

  • Include knockout/knockdown samples as negative controls

  • Use co-localization with established membrane markers

  • Consider GFP-tagged ABCG22 constructs for validation, similar to approaches with related transporters

Advanced Visualization Techniques:

  • Confocal microscopy for membrane localization within tissue layers

  • Super-resolution microscopy for detailed membrane distribution patterns

  • Immunogold electron microscopy for precise subcellular localization

Artifact Prevention:

  • Control for plant tissue autofluorescence through spectral imaging

  • Use Sudan Black B treatment to reduce lipid-associated background

  • Implement stringent blocking to minimize non-specific binding

These approaches enable accurate visualization of ABCG22 distribution in plant tissues, providing insights into its potential role in drought responses and water homeostasis regulation.

How do I interpret conflicting results between different anti-ABCG22 antibodies?

When facing conflicting results between different anti-ABCG22 antibodies, a systematic analytical approach is required:

  • Epitope Mapping Analysis:

    • Determine the specific regions recognized by each antibody

    • Evaluate whether different domains might be accessible in different experimental conditions

    • Consider whether post-translational modifications might affect epitope recognition

  • Validation Reassessment:

    • Review validation data for each antibody against genetic controls

    • Implement additional specificity tests including peptide competition assays

    • Consider that antibodies may detect "different binding modes associated with specific ligands"

  • Experimental Condition Optimization:

    • Systematically test fixation methods, extraction buffers, and detection protocols

    • Create a matrix of conditions to identify optimal parameters for each antibody

    • Document conditions that reconcile conflicting results

  • Cross-reactivity Investigation:

    • Evaluate potential recognition of related ABC transporters

    • Consider that "clinically relevant mutations in the ABCG2 transporter" affect detection

    • Use heterologous expression systems to test specificity

  • Data Integration Framework:

    • Develop a comprehensive table comparing results across antibodies, conditions, and controls

    • Look for patterns that might explain discrepancies (degradation, processing, conformational states)

    • Consider whether different antibodies might detect different functional states of ABCG22

Remember that discrepancies between antibodies can reveal important biological insights about protein processing, post-translational modifications, or protein-protein interactions rather than simply representing technical problems.

What are common sources of background when using ABCG22 antibodies and how can they be minimized?

Background issues are common when working with membrane protein antibodies. Here are the primary sources and mitigation strategies for ABCG22 research:

Background SourceCauseMitigation Strategy
Cross-reactivity with related transportersSequence homology between ABC family membersUse peptide competition assays; include knockout controls
Non-specific membrane bindingHydrophobic interactions with lipid-rich environmentsOptimize blocking (PBS-T+5% milk) ; include detergents in wash buffers
Insufficient washingResidual antibody increases backgroundImplement multiple washing steps (5× with PBS-T for 5 min each with agitation)
Sample preparation artifactsIncomplete solubilization causing aggregatesOptimize extraction buffers for membrane proteins; centrifuge samples before loading
Secondary antibody backgroundNon-specific binding of detection antibodiesInclude secondary-only controls; pre-absorb secondary antibodies if necessary
Endogenous enzymesInterference with enzymatic detection methodsInclude quenching steps before antibody incubation
Plant tissue autofluorescencePhenolic compounds and chlorophyllUse appropriate filters; implement background subtraction algorithms

For quantitative analyses, implement standardized background correction protocols and clearly report them to ensure reproducibility between experiments. The use of sophisticated image analysis software can help distinguish true signal from background.

How can I distinguish between ABCG22 and other closely related ABC transporters in my experiments?

Distinguishing between similar ABC transporters requires multi-faceted approaches:

  • Strategic Epitope Selection:

    • Choose antibodies targeting unique regions of ABCG22

    • Perform comprehensive sequence alignments to identify discriminating regions

    • Apply "inference and design of antibody specificity" approaches to develop highly specific detection tools

  • Genetic Verification:

    • Use knockout/knockdown lines as definitive controls

    • Implement "genetic analysis linked to protein expression measurements" to identify mutations affecting specific transporters

    • Create comparative expression profiles across multiple mutant lines

  • Expression Pattern Analysis:

    • Map tissue-specific and subcellular expression patterns

    • Identify unique localization signatures for different transporters

    • Use co-localization studies with known markers

  • Functional Characterization:

    • Develop assays specific to ABCG22 function

    • For ABCG22, measure parameters related to "transpiration through an influence on stomatal regulation"

    • Compare phenotypes in knockout/overexpression lines

  • Protein Interaction Profiles:

    • Identify specific interaction partners using co-immunoprecipitation

    • Develop interaction maps for different transporters

    • Use differential interaction profiles for discrimination

  • Mass Spectrometry Discrimination:

    • Apply targeted proteomics to detect peptides unique to ABCG22

    • Develop multiple reaction monitoring (MRM) assays for specific quantification

    • Use isotope-labeled standards for absolute quantification

These approaches used in combination provide reliable distinction between closely related transporters, with genetic controls being particularly valuable for validation.

How can ABCG22 antibodies be used to study transporter function in membrane systems?

ABCG22 antibodies enable multiple research approaches to investigate transporter function:

  • Localization and Trafficking Studies:

    • Map subcellular distribution using immunohistochemistry

    • Track dynamic relocalization during stress responses

    • Investigate membrane microdomain associations

    • Quantify changes in membrane abundance under different conditions

  • Protein-Protein Interaction Networks:

    • Identify interaction partners through co-immunoprecipitation

    • Study complex formation and stability

    • Investigate how interactions change during environmental stress

    • Map protein complexes involved in stomatal regulation

  • Post-translational Modification Analysis:

    • Develop modification-specific antibodies (phosphorylation, ubiquitination)

    • Immunoprecipitate ABCG22 for modification analysis by mass spectrometry

    • Correlate modifications with transporter activity and localization

    • Study regulatory mechanisms of transporter function

  • Structure-Function Relationships:

    • Use domain-specific antibodies to probe accessibility in different conformations

    • Compare wild-type and mutant forms as demonstrated for related transporters

    • Investigate structural changes during transport cycles

  • Quantitative Expression Analysis:

    • Measure expression levels across tissues, developmental stages, and stress conditions

    • Apply "quantitative protein expression measurements" methodologies

    • Correlate expression with physiological parameters like transpiration rate

These approaches provide mechanistic insights into how ABCG22 contributes to plant water homeostasis and stress responses, informing both basic understanding and potential agricultural applications.

What role does ABCG22 play in drought resistance mechanisms in plants?

Evidence from genetic studies suggests ABCG22 is a critical component in plant water regulation:

  • Stomatal Regulation:

    • Mutant analysis shows "atabcg22 mutant plants had lower leaf temperatures and increased water loss, implying elevated transpiration through an influence on stomatal regulation"

    • This indicates ABCG22 normally functions to limit water loss through stomata

    • Antibodies can track changes in expression and localization during water stress

  • Potential Transport Substrates:

    • As an ABC transporter, ABCG22 likely transports specific molecules across membranes

    • Candidate substrates include:

      • Phytohormones involved in stomatal closure (ABA or precursors)

      • Secondary messengers in drought signaling pathways

      • Lipids affecting guard cell membrane properties

    • Immunolocalization can help identify cellular pathways involving ABCG22

  • Stress Response Integration:

    • ABCG22 may link multiple stress response pathways

    • Antibodies allow tracking of expression changes during:

      • Drought stress

      • Temperature stress

      • Salt stress

      • Combined stresses

  • Research Applications:

    • Compare ABCG22 expression patterns between drought-resistant and sensitive varieties

    • Study co-regulation with known drought response components

    • Use antibodies to screen germplasm for desirable ABCG22 variants

The evidence suggests ABCG22 functions as a negative regulator of transpiration, potentially through transport of signaling molecules that promote stomatal closure under water-limited conditions.

How can antibodies be used to study ABCG22 mutations and their effects on protein expression?

Antibodies provide powerful tools for investigating the functional consequences of ABCG22 mutations:

  • Quantitative Expression Analysis:

    • Western blotting to compare protein levels between wild-type and mutant plants

    • Flow cytometry to identify "individuals with low level expression"

    • Create expression profiles across tissues and conditions for different mutants

  • Subcellular Localization Studies:

    • Immunolocalization to determine if mutations affect proper targeting

    • Similar to studies of mutations that "result in impaired protein folding, abrogated glycosylation and membrane surface expression"

    • Compare distribution patterns between wild-type and mutant proteins

  • Protein Stability Assessment:

    • Pulse-chase experiments with immunoprecipitation to measure protein turnover rates

    • Investigate if mutations lead to enhanced degradation

    • Study potential protective mechanisms against degradation

  • Structure-Function Correlations:

    • Use domain-specific antibodies to investigate structural alterations

    • Map critical regions for stability and function

    • Create comprehensive mutation tables correlating sequence changes with:

      • Expression levels

      • Subcellular localization

      • Protein stability

      • Plant phenotypes

  • Population-level Studies:

    • Screen plant populations for natural ABCG22 variants

    • Similar to approaches that establish "population-level frequency of genetic variations"

    • Correlate variants with expression levels and drought resistance phenotypes

These approaches can identify critical regions of ABCG22 necessary for proper expression and function, potentially revealing targets for breeding programs or biotechnological interventions aimed at improving plant water use efficiency.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.